New insider activity at Vicarious Surgical ( (RBOT) ) has taken place on February 22, 2025.
Recent financial disclosures reveal that key executives at Vicarious Surgical have offloaded some of their stock. CEO Adam David Sachs has sold 943 shares, generating $13,701 from the transaction. Meanwhile, CTO Sammy Khalifa has parted with 754 shares, amassing $10,955. These sales reflect significant movements within the company’s leadership ranks.
Recent Updates on RBOT stock
In the last 24 hours, Vicarious Surgical announced that its Chief Operating Officer, John Mazzola, will retire effective April 1, 2025. Mazzola, who has been instrumental in advancing the company’s manufacturing processes and supply chain resilience, is stepping down after nearly four decades in healthcare manufacturing and quality control. His responsibilities will transition to Randy Clark, the current President of Vicarious Surgical. This leadership change positions the company for its upcoming clinical use cases and pivotal trials. The market reaction to this announcement was influenced by the company’s strengthened position due to Mazzola’s contributions, although no specific price target changes have been noted in the reports. Overall, the sentiment around Vicarious Surgical remains steady, with a consensus ‘Hold’ rating.
More about Vicarious Surgical
YTD Price Performance: 5.64%
Average Trading Volume: 51,706
Technical Sentiment Consensus Rating: Hold
Current Market Cap: $86.38M
Questions or Comments about the article? Write to editor@tipranks.com